The Window of Opportunity: Why Early Biologic Use Matters for Patients With Hidradenitis Suppurativa

Panelists discuss the critical importance of early biologic therapy initiation in hidradenitis suppurativa to prevent irreversible tissue damage, reduce disease burden, and overcome socioeconomic and systemic barriers that delay timely treatment and worsen patient outcomes.